Publication

Internally Controlled, Multiplex Real-Time Reverse Transcription PCR for Dengue Virus and Yellow Fever Virus Detection

Downloadable Content

Persistent URL
Last modified
  • 05/14/2025
Type of Material
Authors
    Alehandta Rojas, Universidad Nacional de AsunciónCheikh T. Diagne, Institut Pasteur de DakarVictoria D. Stittleburg, Emory UniversityAlisha Mohamed-Hadley, Stanford UniversityYvalena Arevalo de Guillen, Universidad Nacional de AsunciónAngel Balmaseda, Ministry of Health, NicaraguaOumar Faye, Institut Pasteur de DakarOusmane Faye, Institut Pasteur de DakarAmadou A. Sall, Institut Pasteur de DakarEva Harris, Sustainable Sciences Institute, NicaraguaBenjamin A. Pinsky, Stanford UniversityJesse Waggoner, Emory University
Language
  • English
Date
  • 2018-01-01
Publisher
  • American Society of Tropical Medicine and Hygiene
Publication Version
Copyright Statement
  • Copyright © 2018 by The American Society of Tropical Medicine and Hygiene.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0002-9637
Volume
  • 98
Issue
  • 6
Start Page
  • 1833
End Page
  • 1836
Grant/Funding Information
  • The research was supported by the National Institutes of Health (NIH) grant K08AI110528 (J. J. W., salary support); and a Robert E. Shope International Fellowship in Infectious Diseases (J. J. W.) distributed by the American Society of Tropical Medicine and Hygiene.
  • Research was also supported by a fellowship from the Consejo Nacional de Ciencia y Tecnología (CONACYT) of Paraguay, awarded as part of the Programa de Vinculación de Científicos y Tecnólogos, PVCT 16-66 (A. R.).
Supplemental Material (URL)
Abstract
  • The differential diagnosis of dengue virus (DENV) and yellow fever virus (YFV) infections in endemic areas is complicated by nonspecific early clinical manifestations. In this study, we describe an internally controlled, multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) for the detection of DENV and YFV. The DENV–YFV assay demonstrated specific detection and had a dynamic range of 2.0–8.0 log10 copies/µL of eluate for each DENV serotype and YFV. Clinical performance was similar to a published pan-DENV assay: 48/48 acute-phase samples from dengue cases were detected in both assays. For YFV detection, mock samples were prepared with nine geographically diverse YFV isolates over a range of concentrations. The DENV–YFV assay detected 62/65 replicates, whereas 54/65 were detected using a reference YFV rRT-PCR. Given the reemergence of DENV and YFV in areas around the world, the DENV–YFV assay should be a useful tool to narrow the differential diagnosis and provide early case detection.
Author Notes
  • Jesse J. Waggoner, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, 1760 Haygood Dr. NE, Atlanta, GA 30329. E-mail: jesse.j.waggoner@emory.edu
Keywords
Research Categories
  • Biology, Virology
  • Health Sciences, Public Health
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items